Eddy Saad

476 total citations
48 papers, 193 citations indexed

About

Eddy Saad is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Eddy Saad has authored 48 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 19 papers in Oncology. Recurrent topics in Eddy Saad's work include Renal cell carcinoma treatment (20 papers), Scoliosis diagnosis and treatment (13 papers) and Spinal Fractures and Fixation Techniques (12 papers). Eddy Saad is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Scoliosis diagnosis and treatment (13 papers) and Spinal Fractures and Fixation Techniques (12 papers). Eddy Saad collaborates with scholars based in United States, Lebanon and France. Eddy Saad's co-authors include Renée Maria Saliby, Ayman Assi, Ismat Ghanem, Wafa Skalli, Abir Massaad, Rami Rachkidi, Virginie Lafage, Gaby Kreichati, Toni K. Choueiri and David A. Braun and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Eddy Saad

35 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eddy Saad United States 7 128 62 48 33 25 48 193
Nina R. Sluiter Netherlands 9 144 1.1× 37 0.6× 61 1.3× 59 1.8× 41 1.6× 11 229
Yusuke Takahashi Japan 10 77 0.6× 20 0.3× 64 1.3× 88 2.7× 54 2.2× 37 225
Bibek Das United Kingdom 6 71 0.6× 26 0.4× 22 0.5× 56 1.7× 38 1.5× 21 170
Xiu‐He Lv China 10 135 1.1× 9 0.1× 114 2.4× 44 1.3× 58 2.3× 29 273
Jesper Nors Denmark 7 50 0.4× 37 0.6× 41 0.9× 105 3.2× 26 1.0× 15 175
Junke Fu China 8 188 1.5× 19 0.3× 173 3.6× 58 1.8× 23 0.9× 28 277
Margherita Serra Italy 8 147 1.1× 51 0.8× 16 0.3× 26 0.8× 22 0.9× 19 222
Tianhu Wang China 9 78 0.6× 11 0.2× 112 2.3× 82 2.5× 46 1.8× 17 234
Mariëtte van Kouwen Netherlands 4 52 0.4× 35 0.6× 47 1.0× 22 0.7× 15 0.6× 7 100

Countries citing papers authored by Eddy Saad

Since Specialization
Citations

This map shows the geographic impact of Eddy Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddy Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddy Saad more than expected).

Fields of papers citing papers by Eddy Saad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddy Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddy Saad. The network helps show where Eddy Saad may publish in the future.

Co-authorship network of co-authors of Eddy Saad

This figure shows the co-authorship network connecting the top 25 collaborators of Eddy Saad. A scholar is included among the top collaborators of Eddy Saad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddy Saad. Eddy Saad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abu‐Remaileh, Muhannad, Laura Stransky, Nitin H. Shirole, et al.. (2025). Targeting of HIF2-driven cachexia in kidney cancer. Nature Medicine. 32(1). 245–257.
2.
Saliby, Renée Maria, Eddy Saad, Xiaowen Liu, et al.. (2025). KIM-1 as a circulating biomarker in metastatic RCC: Post-hoc analysis of JAVELIN Renal 101.. Journal of Clinical Oncology. 43(5_suppl). 594–594. 1 indexed citations
3.
Saad, Eddy, Renée Maria Saliby, Emre Yekedüz, et al.. (2025). Circulating kidney injury molecule-1 (KIM-1) in association with kidney injury biomarkers and outcomes in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 582–582. 1 indexed citations
4.
Morgan, Paul, Thomas Denize, Sachet A. Shukla, et al.. (2025). 831 AXL Receptor Tyrosine Kinase Expression in Metastatic Renal Cell Carcinoma: Insights from the METEOR trial. Laboratory Investigation. 105(3). 103064–103064. 1 indexed citations
5.
Saliby, Renée Maria, Eddy Saad, Soki Kashima, David A. Schoenfeld, & David A. Braun. (2024). Update on Biomarkers in Renal Cell Carcinoma. American Society of Clinical Oncology Educational Book. 44(2). e430734–e430734. 16 indexed citations
6.
Yekedüz, Emre, David A. Braun, Chris Labaki, et al.. (2024). 24 Applying genomic analysis to refine unclassified renal cell carcinoma. The Oncologist. 29(Supplement_1). S20–S20. 1 indexed citations
7.
8.
Denize, Thomas, Maxine Sun, Renée Maria Saliby, et al.. (2024). Expression of the receptor tyrosine kinase AXL and clinical outcomes to cabozantinib and everolimus in patients with metastatic renal cell carcinoma enrolled in the METEOR trial.. Journal of Clinical Oncology. 42(16_suppl). 4543–4543. 2 indexed citations
9.
10.
Saad, Eddy, Chris Labaki, Renée Maria Saliby, et al.. (2024). 22 Association of a germline single nucleotide polymorphism (SNP) in the interleukin-7 (IL7) gene with immune-related adverse events (irAEs). The Oncologist. 29(Supplement_1). S1–S2.
11.
Saliby, Renée Maria, Eddy Saad, Emre Yekedüz, et al.. (2024). 59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The Oncologist. 29(Supplement_1). S1–S1.
12.
Gupta, Sumati, Pradeep Khanna, Eddy Saad, et al.. (2024). 55 (PB043): Activity of CDK4/6 inhibitors in translocation renal cell carcinoma. European Journal of Cancer. 211. 114582–114582.
13.
Choi, Sharon, Roxanne Quinn, Eddy Saad, et al.. (2024). Efficacy of post-lenvatinib treatments in patients (pts) with advanced renal cell carcinoma (aRCC).. Journal of Clinical Oncology. 42(16_suppl). 4538–4538. 2 indexed citations
14.
Labaki, Chris, Renée Maria Saliby, Ziad Bakouny, et al.. (2023). Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma. Hematology/Oncology Clinics of North America. 37(5). 937–942. 6 indexed citations
15.
Saad, Eddy, Renée Maria Saliby, Chris Labaki, et al.. (2023). Novel Immune Therapies for Renal Cell Carcinoma. Hematology/Oncology Clinics of North America. 37(5). 1027–1040. 1 indexed citations
16.
Assi, Ayman, Rami Rachkidi, Eddy Saad, et al.. (2023). ASD with high pelvic retroversion develop changes in their acetabular orientation during walking. SHILAP Revista de lepidopterología. 3. 101752–101752. 4 indexed citations
17.
18.
Skalli, Wafa, Rami Rachkidi, Hélène Pillet, et al.. (2022). Assessment of dynamic balance during walking in patients with adult spinal deformity. European Spine Journal. 31(7). 1736–1744. 6 indexed citations
19.
Saliby, Renée Maria, Rami Rachkidi, Abir Massaad, et al.. (2021). Gait kinematic alterations in subjects with adult spinal deformity and their radiological determinants. Gait & Posture. 88. 203–209. 25 indexed citations
20.
Saad, Eddy, et al.. (2021). Reliability assessment of cervical spine parameters measured on full-body radiographs in asymptomatic subjects and patients with spinal deformity. Orthopaedics & Traumatology Surgery & Research. 107(7). 103026–103026. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina R. Sluiter Breakdown of academic impact, for papers by Yusuke Takahashi Breakdown of academic impact, for papers by Bibek Das Breakdown of academic impact, for papers by Xiu‐He Lv Breakdown of academic impact, for papers by Jesper Nors Breakdown of academic impact, for papers by Junke Fu Breakdown of academic impact, for papers by Margherita Serra Breakdown of academic impact, for papers by Tianhu Wang Breakdown of academic impact, for papers by Mariëtte van Kouwen
Rankless by CCL
2026